Clinical Trial Site

Milan, Lombardy 20141

3 studies enrolling now · 3 studies all time

What they study most

Acid Cholesteryl Ester Hydrolase Deficiency, Type 2, Acid Lipase Deficiency, Advanced Breast Cancer, Breast Cancer, Cholesterol Ester Storage Disease, ER Positive Breast Cancer, HER2 Negative Breast Carcinoma, LAL-Deficiency, LIPA Deficiency, Locally Advanced Breast Cancer, Lysosomal Acid Lipase Deficiency, Metastatic Breast Cancer

Studies at this site

• Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer — Recruiting now
• OP-1250 (Palazestrant) vs. Standard of Care for the Treatment of ER+/HER2- Advanced Breast Cancer — Recruiting now
• Lysosomal Acid Lipase (LAL) Deficiency Registry — Recruiting now